Arvinas ($ARVN) Insider Trading & Smart Money Activity
Arvinas, Inc. ($ARVN) has 8 insider trades and 2 13F position changes on file. In the last 12 months on the open market, no insider bought and 2 insiders sold ($66.06K), net -$66.06K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 2
- Net insider $ (12 mo)
- -$66.06K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 2
- Analyst ratings on file
- 0
ARVN insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 2 · $66.06K | 0 / 0 | 0 / 2 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All ARVN insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Smaldone Alsup Laurie | Buy (Grant or award) | 15.53K sh | +1.9% | -0.2% | Read | |||||
| Insider | Andrew SaikChief Financial Officer | Sell (Open-market sale) 10b5-1 | 5.70K sh | $46.48K | +1.9% | -0.2% | — | ||||
| Insider | Leslie Norwalk | Buy (Grant or award) | 15.53K sh | +1.9% | -0.2% | Read | |||||
| Insider | Briggs Morrison | Buy (Grant or award) | 22.71K sh | +1.9% | -0.2% | Read | |||||
| Insider | Kennedy Edward Moore JR. | Buy (Grant or award) | 15.53K sh | +1.9% | -0.2% | Read | |||||
| Insider | Everett Cunningham | Buy (Grant or award) | 15.53K sh | +1.9% | -0.2% | Read | |||||
| Insider | Linda Bain | Buy (Grant or award) | 22.71K sh | +1.9% | -0.2% | Read | |||||
| Insider | Angela CacaceChief Scientific Officer | Sell (Open-market sale) 10b5-1 | 2.58K sh | $19.58K | +5.0% | +4.4% | — | ||||
| 13F | Dekabank Deutsche Girozentrale | Sold out | -42K sh | -7.6% | -29.8% | — | |||||
| 13F | Dekabank Deutsche Girozentrale | Sold out | -42K sh | -7.6% | -29.8% | — |
1W / 1M / 6M = how ARVN moved from the trade or filing date.
Insider trading in ARVN: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Smaldone Alsup Laurie | 1 | — | Jun 24, 2026 | ||
| Andrew Saik | Chief Financial Officer | 1 | -$46.48K | Jun 24, 2026 | |
| Leslie Norwalk | 1 | — | Jun 24, 2026 | ||
| Briggs Morrison | 1 | — | Jun 24, 2026 | ||
| Kennedy Edward Moore JR. | 1 | — | Jun 24, 2026 | ||
| Everett Cunningham | 1 | — | Jun 24, 2026 | ||
| Linda Bain | 1 | — | Jun 24, 2026 | ||
| Angela Cacace | Chief Scientific Officer | 1 | -$19.58K | Jun 17, 2026 |
Institutions moving ARVN (13F)
Frequently asked questions
Are ARVN insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 2 insiders made 2 open-market sales worth $66.06K, a net -$66.06K.
What is the latest insider trade in ARVN?
Smaldone Alsup Laurie filed a buy (grant or award) of 15.53K sh on Jun 24, 2026.
Which institutions changed their ARVN positions?
Recent 13F filers moving the stock include Dekabank Deutsche Girozentrale.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.